Search Results

Search Results for

UTX-TGR-205

Study to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins Lymphoma (UNITY-NHL)

Continue Reading »
SGN35-027

Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma

Continue Reading »
C2321001

PF-06821497 Treatment Of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

Continue Reading »
EA4181

A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly Diagnosed Mantle Cell Lymphoma

Continue Reading »
S1826

Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma

Continue Reading »
TG-1501-101

A Phase 1 Study of TG-1501 in Subjects With Relapsed or Refractory Lymphoma

Continue Reading »
E4412

Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

Continue Reading »
S1608

Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma

Continue Reading »

Search Again